Close Menu

NEW YORK (GenomeWeb) – RainDance Technologies has filed a prospectus for an initial public offering of its stock for up to $60 million.

Billerica, Mass.-based RainDance has neither priced its shares nor said how many shares it plans to offer, but said in its Form S-1 filed with the US Securities and Exchange Commission that it plans to trade on the NASDAQ under ticker symbol "RAIN."

Merrill Lynch, Cowen and Company, and Evercore ISI Group are listed as the offering's underwriters.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nobel laureates and scientific societies urge NIH and the Department of Health and Human Services to revisit the recent decision to end funding for a coronavirus grant.

Bloomberg reports that BGI's SARS-CoV-2 testing sites in the Middle East have raised concerns among US officials.

A new Pew Research Center poll finds confidence in medical researchers has grown among US adults since the start of the coronavirus pandemic.

In Science this week: machine learning algorithm for faster Mendelian disorder diagnoses, gene linked to safe response to nitrogen-containing bisphosphonates, and more.